With the American consumer running out of breath amid an economic slowdown in the second half of 2025, Stifel sees a selloff ...

McCormick & Company Inc. (NYSE:MKC) is one of the best defensive stocks to invest in according to analysts. In its Q2 2025 ...

Stifel Nicolaus analyst Jonathan Siegmann CFA reiterated a Buy rating on Parsons today and set a price target of $83.00. The company’s shares closed yesterday at $75.92. Take advantage of TipRanks ...

Fintel reports that on August 8, 2025, Stifel downgraded their outlook for Crocs (NasdaqGS:CROX) from Buy to Hold. Analyst ...

Stifel cut its rating on Crocs (NASDAQ:CROX) to Hold from Buy, saying murky revenue trends and uncertainty around topline growth through 2026 weaken the investment case despite strong margins and cash ...

Chairman and CEO Ron Kruszewski called it the financial services company's best quarter for recruitment in nearly 10 years.

Baxter (NYSE:BAX) downgraded to Hold by Stifel after weak Q2 earnings, lowered guidance, and operational challenges. Read ...

Detailed price information for Abcellera Biologics Inc (ABCL-Q) from The Globe and Mail including charting and trades.

The 12-month price targets, analyzed by analysts, offer insights with an average target of $126.25, a high estimate of ...

The St. Louis-based investment banker and wealth manager saw a brisk second half of the quarter after the fallout from the ...

An Osaic Wealth financial advisor recommended that one customer, an 84-year-old widow, invest in the fund in May, days before ...